Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?

Dirk Rades

doi:10.1016/j.oraloncology.2008.03.015

Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?

Dirk Rades^*

^*Corresponding author for this work

Department of Radiotherapy

5 Citations (Scopus)

Original language	English
Journal	Oral Oncology
Volume	45
Issue number	2
Pages (from-to)	91-93
Number of pages	3
ISSN	1368-8375
DOIs	https://doi.org/10.1016/j.oraloncology.2008.03.015
Publication status	Published - 02.2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.oraloncology.2008.03.015

Cite this

@article{b14e3a3a097d4968a08441fe708f0bd8,

title = "Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?",

author = "Dirk Rades",

year = "2009",

month = feb,

doi = "10.1016/j.oraloncology.2008.03.015",

language = "English",

volume = "45",

pages = "91--93",

journal = "Oral Oncology",

issn = "1368-8375",